๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ulcerative colitis exacerbating after placement of intragastric balloon for the treatment of obesity

โœ Scribed by Francesco Manguso; Salvatore Picascia; Antonio Balzano


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
53 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Rapid onset of ulcerative colitis after
โœ Antonio Tursi ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB

infliximab. In contrast, similar psoriasiform lesions are reported to have been induced by infliximab in a few patients with inflammatory bowel diseases. [3][4][5][6][7] Such an undesired, dermatologically adverse effect is considered a delayed hypersensitivity reaction that commonly occurs during v

Exogenous alkaline phosphatase for the t
โœ Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Fra ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Background: Increased activity of intestinal alkaline phosphatase (AP) occurs locally in patients with ulcerative colitis (UC), aimed at repairing inflammatory tissue damage. We evaluated the safety and preliminary efficacy of exogenous AP administered to patients with UC in an open-label, first-in-

Fecal calprotectin mirrors inflammation
โœ Mikko P. Pakarinen; Antti Koivusalo; Johanna Natunen; Merja Ashorn; Riitta Karik ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB

## Background: The goal was to cross-sectionally assess fecal calprotectin after restorative proctocolectomy for pediatric-onset ulcerative colitis (uc). ## Methods: Fecal calprotectin, histology of the distal ileum, inflammation biochemistry, episodes of pouchitis, and bowel function were cross-

Optimal apheresis treatment volume for t
โœ Ken Fukunaga; Koji Kamikozuru; Yoko Yokoyama; Nobuyuki Hida; Yoshio Ohda; Naohis ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB

## Abstract **Background**: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight (BW) adjusted volume. **Methods*